Mori, H., Kubo, M., Nishimura, R., Osako, T., Arima, N., Okumura, Y., . . . Nakamura, M. (2016). BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer. PLoS One.
Styl cytowania ChicagoMori, Hitomi, et al. "BRCAness As a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer." PLoS One 2016.
Styl cytowania MLAMori, Hitomi, et al. "BRCAness As a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer." PLoS One 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..